Utilize este identificador para referenciar este registo:
https://hdl.handle.net/10316/25539
Título: | Tumor-targeted Chlorotoxin-coupled Nanoparticles for Nucleic Acid Delivery to Glioblastoma Cells: A Promising System for Glioblastoma Treatment | Autor: | Costa, Pedro M. Cardoso, Ana L. Mendonça, Liliana S. Serani, Angelo Custódia, Carlos Conceição, Mariana Simões, Sérgio Moreira, João N. Almeida, Luis Pereira de Lima, M. C. P. de |
Palavras-chave: | chlorotoxin; glioblastoma; liposome; miR-21; stable nucleic acid lipid particle | Data: | 2013 | Editora: | The American Society of Gene & Cell Therapy | Título da revista, periódico, livro ou evento: | Molecular Therapy—Nucleic Acids | Volume: | 2 | Número: | Artigo e100 | Resumo: | The present work aimed at the development and application of a lipid-based nanocarrier for targeted delivery of nucleic acids to glioblastoma (GBM). For this purpose, chlorotoxin (CTX), a peptide reported to bind selectively to glioma cells while showing no affinity for non-neoplastic cells, was covalently coupled to liposomes encapsulating antisense oligonucleotides (asOs) or small interfering RNAs (siRNAs). The resulting targeted nanoparticles, designated CTX-coupled stable nucleic acid lipid particles (SNALPs), exhibited excellent features for in vivo application, namely small size (<180 nm) and neutral surface charge. Cellular association and internalization studies revealed that attachment of CTX onto the liposomal surface enhanced particle internalization into glioma cells, whereas no significant internalization was observed in noncancer cells. Moreover, nanoparticle-mediated miR-21 silencing in U87 human GBM and GL261 mouse glioma cells resulted in increased levels of the tumor suppressors PTEN and PDCD4, caspase 3/7 activation and decreased tumor cell proliferation. Preliminary in vivo studies revealed that CTX enhances particle internalization into established intracranial tumors. Overall, our results indicate that the developed targeted nanoparticles represent a valuable tool for targeted nucleic acid delivery to cancer cells. Combined with a drug-based therapy, nanoparticle-mediated miR-21 silencing constitutes a promising multimodal therapeutic approach towards GBM. | URI: | https://hdl.handle.net/10316/25539 | DOI: | 10.1038/mtna.2013.30 | Direitos: | openAccess |
Aparece nas coleções: | FCTUC Ciências da Vida - Artigos em Revistas Internacionais |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
mtna201330a(1).pdf | 3.99 MB | Adobe PDF | Ver/Abrir |
Citações SCOPUSTM
82
Visto em 11/nov/2022
Citações WEB OF SCIENCETM
1
78
Visto em 2/mai/2023
Visualizações de página 50
499
Visto em 25/set/2024
Downloads 50
553
Visto em 25/set/2024
Google ScholarTM
Verificar
Altmetric
Altmetric
Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.